18,21-didesoxymacbecin derivatives for the treatment of cancer

Details for Australian Patent Application No. 2007247121 (hide)

Owner Biotica Technology Limited

Inventors Martin, Christine; Moss, Steven; Coates, Nigel; Zhang, Ming; Vousden, William; Gaisser, Sabine

Agent Davies Collison Cave

Pub. Number AU-A-2007247121

PCT Pub. Number WO2007/128829

Priority 0609132.6 09.05.06 GB; 0616637.5 22.08.06 GB; 0622341.6 09.11.06 GB

Filing date 9 May 2007

Wipo publication date 15 November 2007

International Classifications

C07D 225/06 (2006.01) Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

6 November 2008 PCT application entered the National Phase

  PCT publication WO2007/128829 Priority application(s): WO2007/128829

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007247136-Use of arylcarboxylic acid biphenylamides for seed treatment

2007247119-17-oxymacbecin derivatives and their use in the treatment of cancer and/or Bcell malignancies